US › Healthcare

Instil Bio Inc. (TIL)

US · Healthcare · Biotechnology

$5.91-3.59%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-4.3M

EPS

$-0.63

EPS estimate

$-0.35

EPS came in at -0.63 against a street estimate of -0.35 — a miss of 80.0%.

Key statistics

Market cap

$40.1M

Forward P/E

0.0

P/B

0.46

Book value

$15.83

EPS (TTM)

$-4.43

52-week high

$20.32

52-week low

$5.67

50-day MA

$7.22

200-day MA

$7.80

Beta

1.94

Analyst view

Analysts rate Instil Bio Inc. a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $7.00.

Shareholding

Insiders

6.56%

Institutions

62.50%

Largest institutional holders

Fund	Stake
BML Capital Management LLC	9.52%
Cpmg Inc	6.06%
Vivo Capital, LLC	4.32%
Kalehua Capital Management LLC	2.94%
UBS Group AG	2.62%
Vanguard Capital Management, LLC	2.41%
Millennium Management LLC	1.98%
BlackRock Inc	0.82%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Instil Bio Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.